Loading…

Exploiting next-generation sequencing in antibody selections - a simple PCR method to recover binders

Antibody discovery using display technologies such as phage and/or yeast display has become acornerstone in many research and development projects, including the creation of new drugs for clinical use. Traditionally, after the selection phase, random clones are isolated for binding validation and Sa...

Full description

Saved in:
Bibliographic Details
Published in:mAbs 2020-01, Vol.12 (1), p.1701792-1701792
Main Authors: Ferrara, Fortunato, Teixeira, Andre A, Naranjo, Leslie, Erasmus, M Frank, D'Angelo, Sara, Bradbury, Andrew R M
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Antibody discovery using display technologies such as phage and/or yeast display has become acornerstone in many research and development projects, including the creation of new drugs for clinical use. Traditionally, after the selection phase, random clones are isolated for binding validation and Sanger sequencing. More recently, next-generation sequencing (NGS) technology has allowed deeper insight into the antibody population after aselection campaign, enabling the identification of many more specific binders. However, this approach only provides the DNA sequences of potential binders, the properties of which need to be fully elucidated by obtaining corresponding clones and expressing them for further validation. Here we present arapid novel method to harvest potential clones identified by NGS that uses asimple PCR and yeast recombination approach. The protocol was tested in selections against three different targets and was able to recover clones at an abundance level that would be impractical to identify using traditional methods.
ISSN:1942-0862
1942-0870
DOI:10.1080/19420862.2019.1701792